Day 4 Recap: Elevate-Derm West 2024

Author(s):

Emma Andrus, Associate Editor

Key Takeaways

Dr. Ashfaq Marghoob emphasized dermoscopic features to differentiate benign from malignant lesions in various body locations.
Dr. Jenny Murase highlighted the unsuitability of small molecule treatments, like JAK inhibitors, for pregnant women.
Dr. Lisa Swanson offered practical strategies for pediatric dermatology, enhancing clinician confidence in treating young patients.
Emerging therapies for severe itch were discussed, providing hope for patients with limited treatment options.

Catch up on coverage from the fourth and final day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

To stay informed with the latest conference insights, subscribe to receive our eNewsletters.

Ashfaq Marghoob, MD: Identifying Dermoscopic Patterns in Facial, Palmoplantar, Nail, and Mucosal Lesions

Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.

Navigating Skin Disease Treatment During Pregnancy

Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.

Pediatric Dermatology Essentials: Lisa Swanson, MD, on Treating Young Patients with Confidence

Swanson shared practical tips from her Elevate-Derm West sessions, empowering clinicians with new strategies for pediatric skin care.

Jenny Murase, MD: Emerging Therapies Bring Hope to Patients with Persistent Itch

At Elevate-Derm West, Murase shared promising results in treating severe itch with emerging therapies, offering hope for patients with few options.

Desert Gems in Dermatology: Insights from Elevate-Derm West 2024

Discover top innovations, insights, and clinical pearls from Elevate-Derm in Scottsdale, where top insights for advanced practice providers took center stage.

To view all conference coverage from Elevate-Derm West 2024, click here.